(Q44888250)

7 December 2017

title

The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice (English)

1 reference

7 December 2017

Tannehill-Gregg SH

1

1 reference

7 December 2017

Kusewitt DF

series ordinal

2

1 reference

7 December 2017

Rosol TJ

series ordinal

3

1 reference

7 December 2017

Weinstein M

series ordinal

4

1 reference

7 December 2017

publication date

1 May 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

41

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

278-282

1 reference

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Smad4 (DPC4)--a potent tumour suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Squamous carcinoma model of humoral hypercalcemia of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Functions of mammalian Smad genes as revealed by targeted gene disruption in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

The transforming growth factor-beta signaling pathway in tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

Smad3 mutant mice develop metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.41-3-278

21 January 2018

Identifiers

DOI

10.1354/VP.41-3-278

1 reference

7 December 2017

1 reference